•  
  •  
  •  
  •  

2025-08-08 21:57:22

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
  • Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
  • Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
  • RBI grants NBFC license to Equirus Group

Keywords Selected:  IZMO

Stock Report

  • izmostock Unveils All-New Global Portal
  • izmo Microsystems partners with IIT Madras for Cutting-Edge Photonic Chip Packaging Solutions
  • IZMO Ltd. receives ISO 27001:2022 Certification, proves its commitment to Data Security
  • IZMO Limited sells property in Bangalore for Rs. 31 crores
  • izmo Ltd. acquires Geronimo Web
  • Izmo Ltd to sell land and building at Bangalore
  • Izmo introduces WarrantyBoost+ for Warranty Rate Enhancement
  • IZMO Ltd consolidated Q3 FY2022-23 net profit soars to Rs. 6.53 crores
  • IZMO Ltd consolidated Q1 FY2023 PAT falls QoQ to Rs. 2.09 crore
  • izmoEmporio featured in Automotive News - a leading automotive publication in US
  • IZMO Ltd posts consolidated Q4 FY2022 net profit of Rs. 6.02 crores
  • izmo launches new product - izmoEmporio - in the US
  • Izmo featured in the esteemed FT's ranking of high-growth top 500 companies in APAC
  • IZMO Ltd reports consolidated PAT of Rs. 6.28 crores in Q3 FY2021-22

Latest Post

  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
  • Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
  • Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
  • RBI grants NBFC license to Equirus Group


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024